NetworkNewsAudio – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) is a Blockchain Company to Watch in 2018

Related Editorial
Blockchain technology and cryptocurrency unarguably have the potential to alter the future of money, finance, transportation and national security. While an increasing number of blockchain plays wind their way through the investment community, Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) (VSQTF Profile) is demonstrating a particular measure of blockchain innovation potential in a wide range of industries, including payment processing, mobile gaming, and more.  Other companies seizing territory in the blockchain technology space include tech-giant IBM (NYSE: IBM), Walmart (NYSE: WMT), Visa (NYSE: V) and Hive BlockChain Technologies (TSX:HIVE.V) (OTC: HVBTF).

To hear the NetworkNewsAudio version, visit: http://nnw.fm/xH95v

To view the full editorial, visit http://nnw.fm/ASNo7

About Victory Square Technologies Inc.

Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.VictorySquare.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsAudio – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Unique Delivery Platform Could be a Breakthrough in Cannabinoid Drug Delivery

Related Editorial
Modern science has substantiated both the anecdotal history and the efficacy of cannabidiol (“CBD”), a non-psychoactive compound found in the cannabis sativa plant. Research has revealed that CBD may significantly reduce inflammation and is now widely used to treat chronic pain, multiple sclerosis and fibromyalgia, epilepsy, and numerous other conditions. There is even evidence that CBD has potential to prevent symptoms of Alzheimer’s and appears to suppress the growth of cancer cells and promote the death of these cells (http://nnw.fm/S6cXu). While CBD may provide solutions to multiple unmet medical needs, current drug delivery techniques remain antiquated. There are inherent metabolic issues in consistent, effective delivery of cannabinoids, and these new pharmaceutical therapeutics require revolutionary techniques of administration. Establishing a new paradigm in cannabinoid drug delivery, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (PRVCF Profile) is engineering a unique Sol-gel nose-to-brain delivery platform to provide direct, controlled pharmacological drug release. Many large Canadian companies produce cutting-edge pharmaceutical cannabis compounds, yet rely on outdated delivery mechanisms and may find PreveCeutical’s platform superior to current dosing techniques. Some of these companies include Canopy Growth Corp. (TSX: WEED) (OTC: TWMJF), Aphria, Inc. (TSX: APH) (OTCQB: APHQF) and Isodiol International, Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F).

To hear the NetworkNewsAudio version, visit: http://nnw.fm/MAut8

To view the full editorial, visit http://nnw.fm/z62Bc

About PreveCeutical Medical Inc.

PreveCeutical Medical Inc. is a health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs, including: dual gene therapy for curative and prevention therapies for diabetes and obesity; a Sol-gel platform for nose to brain delivery of medical compounds including cannabinoids; Nature Identical™ peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster. CELLB9 is an oral solution containing polarized and potentiated essential minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion venom. For more information, visit the company’s website at www.PreveCeutical.com.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Plans 2018 Rollout of Stock Trading App

  • Intesa Sanpaolo is one of the largest banking groups in Europe, with a market cap of 53 billion euro and some 4,700 branches in Italy alone
  • ATIXF’s Marketwall real-time stock trading app is integrated into the banking group’s MarketHub trading platform
  • ATIXF to reach stock-trading clients of Intesa Sanpaolo in six countries

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) plans to integrate its 49 percent-owned fintech subsidiary’s real-time stock trading app, Marketwall, into Italy-based banking group Intesa Sanpaolo during 2018. This will give ATIXF exposure to the group’s eight million stock-trading clients (http://nnw.fm/uv4Bs). The integration is expected to be available in six countries.

AnalytixInsight, developer of artificial intelligence, will have its CapitalCube platform embedded into the financial app, giving users real-time trading information. Also, in agreement with global partner Samsung, the app will be preloaded into Italian smart TVs and other devices. Intesa Sanpaolo is one of Europe’s largest banking groups, with a 53 billion euro market cap and some 4,700 branches in Italy alone (http://nnw.fm/vG41x).

AnalytixInsight is the developer of an AI machine-learning platform that turns big data into actionable information. Workflow information schedules are robotically analyzed for maximum performance. Its product, CapitalCube, is a software-as-a-service (SaaS) platform that offers financial research and analysis for investors, financial portals and media. The Toronto, Ontario, Canada-based company has licensed the technology to the stock exchanges, financial news agencies and web portals. The technology is scalable and adaptable to other industries, such as government, health care, insurance, e-commerce and others.

AnalytixInsight also co-owns Marketwall, a Milan, Italy-based fintech company. ATIXF owns 49 percent of that company. It has partnered with Samsung to make the Marketwall mobile application available on smart devices. In the first half of 2018, the company is expected to roll out to Intesa Sanpaolo’s eight million stock-trading clients. Intesa Sanpaolo is Italy’s largest bank, with more than 4,000 branches, and is co-owner of Marketwall.

For more information, visit the company’s website at www.AnalytixInsight.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Reign Sapphire Corp. (RGNP) Delivers Conflict-Free Gems Directly to Consumers

  • Retail sales of colored gemstones valued from $18 billion to $21 billion
  • RGNP guarantees quality Australian gems that are favorable to modern ethical sensibilities
  • Sapphires regained popularity with British royal engagement and are second only to diamonds in terms of natural hardness

In April 2015, Amnesty International reported that nearly 80 percent of public companies in the United States were failing to thoroughly check whether their supply chains included conflict minerals from nations in Central Africa known to extract the Earth’s riches from the ground amid a variety of human rights abuses (http://nnw.fm/nBe1y). Consumer awareness and Congressional legislation have fueled a growing focus on the ‘ethical’ production of minerals for everything from jewelry to electronics in the years since, and Reign Sapphire Corp. (OTCQB: RGNP) has established such a standard of care in its global direct-to-consumer brand of custom jewelry.

While sapphire production doesn’t typically generate the violence common to diamond mining in some less industrialized nations, about a quarter of the gem’s supply comes from Madagascar, where diggers often work in dangerous conditions, rely on abusive practices such as child labor and don’t rehabilitate the land after mining (http://nnw.fm/bC0ZB). Reign Sapphire, based in Beverly Hills, California, relies on ‘responsible’ mining in Australia and guarantees that its products come from that country, are naturally authentic and are mined in an environmentally-friendly manner.

Australia’s sapphire industry has a history as colorful as the gem itself. According to the mining industry, the quality and quantity of sapphire from Australia was concealed by ‘many international vested interests’ for decades as part of an attempt to control the supply and price of the gems. As a result, Australian sapphires were deceptively branded as coming from other countries where the mineral supply is largely depleted, according to AustralianSapphire.com (http://nnw.fm/XV8r9). Australian producers have begun to take greater control of the marketing of their products in recent years, however.

The sapphire is an aluminum oxide (corundum) gem that is second only to the diamond for hardness in a natural substance. It’s so durable, synthetic versions of it are used for the windows of supermarket scanners and spacecraft. Rubies are a red or pink corundum sibling; all other colors, including blues, greens and yellows, are sapphires. The gem gained new attention and an exponential increase in sales when Prince William provided his deceased mother’s blue-white sapphire-and-diamond cluster as an engagement ring to Kate Middleton. Reign Sapphire CEO Joseph Segelman told the Huffington Post (http://nnw.fm/Q02vC) last year that his company’s focus on ethical production of the stone from the Australian industry means that the company “can guarantee the plot of land practically within a couple feet of where the sapphires were mined from. We can also guarantee that it’s been mined in an ethical way, that the topsoil is environmental and gets replanted [post mining] and made good.”

The Gemological Institute of America (“GIA”) estimated the annual retail sales value of colored gemstones such as sapphires at between $18 billion and $21 billion in a 2016 report on the rise in their popularity (http://nnw.fm/p3Dhb). The GIA noted that the greater transparency in the supply chain of sapphires, as compared to diamonds, is of value in today’s market not only because of the human rights concerns, but also because of the sentimentality of consumers who often prefer jewelry with a backstory to stones of unknown origin.

“Jewelry has always been an emotional purchase, and customers care about the ‘story’ behind their pieces,” the GIA wrote. “Millennials, who have grown up knowledgeable about fair-trade products and sustainability, expect that issues pertaining to human rights, environmental impact, and social consciousness are addressed in the supply chain for the products they wish to purchase.”

Reign Sapphire capitalizes on the desire to trace its jewelry’s supply chain as it delivers stones directly from the mine to the jewelry consumer as part of its direct-to-consumer model. Its niche brands also include its customized Le Bloc jewelry and the personally commemorative inscriptions of the Coordinates Collection.

“Miners are not marketers, marketers are not miners,” Segelman said in the Huffington Post interview. “I happen to have done both which is why I came up with this concept.”

For more information, visit the company’s website at www.ReignSC.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Closes $9M Registered Direct Offering

Clinical stage pharmaceutical company Moleculin Biotech (NASDAQ: MBRX) has closed its offering of 4.29 million registered shares of common stock at a purchase price of $2.10 per share. Concurrently in a private placement, for each share of common stock purchased by an investor, the investor will receive an unregistered warrant to purchase 0.5 of a share of common stock. The warrants are exercisable six months from the date of issuance at a price of $2.80 per share and will expire five years from the initial exercise date. Moleculin intends to use the gross proceeds from the offering, which total approximately $9 million, toward its planned clinical trials, preclinical programs, research and development activities and for general corporate purposes. ROTH Capital Partners acted as sole placement agent for the offering.

For more information, visit www.Moleculin.com.

About Moleculin Biotech, Inc.

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. Our clinical stage drugs are Annamycin, an anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML, and WP1066, a modulator of hard-to-target tumor cell signaling mechanisms intended to attack tumor activity directly while also recruiting the patient’s own immune system. We are also engaged in preclinical development of additional drug candidates, including compounds targeting the metabolism of tumors.

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Earth Science Tech, Inc.’s (ETST) European Industrial Hemp and Mr. Checkout Could be Key Players in 2018

  • ETST projects a breakout year in 2018 from its new line of High Grade Full Spectrum Cannabinoids, marketed as a cannabinoid complex
  • Checkout sells to major retailers, such as Walmart and Target, as well as a network of independent distributors and retail owners
  • ETST’s new line is sourced from European industrial hemp, but it is mixed, bottled and packaged in the U.S.

Earth Science Tech, Inc. (OTC: ETST) is projecting a breakout year in 2018, resetting its executive team and implementing a new marketing strategy. Playing key roles in the predictions of higher volume and performance are new Netherlands-sourced industrial hemp-based products and Mr. Checkout, the specialty distributor that focuses on retail placement (http://nnw.fm/1NpT6).

The company recently launched its revamped and repackaged line of industrial hemp products as a cannabinoid complex. It uses a CO2 extraction process with organically grown and unfiltered industrial hemp. It sources the product from Europe, but it is mixed, bottled and packaged in the U.S. The European Industrial Hemp Association (EIHA) is working with the World Health Organization (WHO) for a product review, and its next meeting is set for May 2018 (http://nnw.fm/6AL1f).

ETST is an innovative biotech company based in Doral, Florida. Its new line consists of High Grade Full Spectrum Cannabinoids product. It is focused on the cannabinoid, nutraceutical and pharmaceutical fields, and it also conducts R&D for certain medical devices. The new cannabinoid complex line is unique, because it offers the user a specific disclosure of the milligrams (mg) of each cannabinoid. The cannabinoid complex is rich in Terpenes and Saponins, ETST said.

Mr. Checkout, a distributor originally launched in 1989, specializes in distribution to major retailers, such as Walmart, Target and Walgreens, and it also to a network of 1,100 independent distributors and 50,000 independent retail owners within a national network in the U.S. It also offers comprehensive logistics expertise in shipping and boasts a ‘Fast Track’ program designed to get product onto retail shelves quickly (http://nnw.fm/kbLY2).

ETST markets a 100 percent natural and organic high grade hemp cannabidiol and holds three wholly-owned subsidiaries: Earth Science Pharmaceutical has a line of low-cost, non-invasive medical devices for the detection of sexually transmitted diseases (STDs); Cannabis Therapeutics is an emerging biotechnology company; and KannaBidioilD is targeted to the recreational market.

For more information, visit the company’s website at www.EarthScienceTech.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) “Seed to Derivatives” – Vertical Integration in Burgeoning Cannabis Market

  • Letter of Intent to acquire Agro-Biotech, to become vertically integrated from “seed to derivatives”
  • Development and commercialization of therapeutic pharmaceuticals and nutraceuticals
  • Patented formulation and delivery technologies

Scientific studies have provided empirical credence to the medical efficacy of cannabinoids for multiple maladies. Globally, researchers and biopharmaceutical companies are now laser focused on cannabinoid-based therapeutics that may hold blockbuster medical potential, providing solutions to a range of unmet medical needs. However, current drug delivery techniques remain antiquated. There are inherent metabolic and bioavailability issues affecting the consistent, effective delivery of cannabinoids. It’s becoming clear that these new pharmaceutical therapeutics require revolutionary delivery techniques.  Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) is establishing new paradigms in cannabinoid drug development and delivery.

Pivot Pharmaceuticals is transforming the development and commercialization of these new therapeutic pharmaceuticals and nutraceuticals with unique drug delivery platform technologies. Pivot’s medical cannabis product division, Pivot Green Stream Health Solutions (PGS), conducts research, development, and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals, and it has acquired worldwide rights to BiPhasix™ Transdermal Drug Delivery platform technology (topical) and Solmic Solubilisation technology (oral) for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. The company recently filed three provisional patents for cannabinoid-based product delivery with the U.S. Patent and Trademark Office (http://nnw.fm/GmkU0), and these latest patent filings join an established number of global rights to topical, oral, transdermal, food and beverage technologies that Pivot has already secured.

Pivot’s pipeline of potential CBD-based pharmaceuticals now covers treatment indications for supportive care to relieve nausea, mucositis and pain, including cancer-related and menstrual pain, dermatological conditions and even glaucoma. Pivot is also developing and commercializing an array of pharmaceutical-grade formulations for cannabinoid-based consumer health care products.

With enhanced drug delivery and development well underway, Pivot has turned to its next business objective, vertical integration. The company just announced a Letter of Intent for the proposed acquisition of Agro-Biotech, a Québec-based ACMPR Canadian licensed cannabis producer (http://nnw.fm/LeZ3q). Agro-Biotech operates a fully licensed, purpose-built, indoor hydroponic cannabis production facility capable of producing a cumulative 10,000 kilograms per year.

Pivot is already a differentiated player in the Canadian cannabis industry due to its unique approach to enhanced dosing and bioavailability of cannabinoids with proven pharmaceutical and patented formulation and delivery systems. With the acquisition of Agro-Biotech, Pivot Pharmaceuticals expects to become vertically integrated, controlling the entire manufacturing process from “seed to derivatives” and capturing margin along the entire supply chain.

In the news release, Dr. Patrick Frankham, Pivot CEO, stated, “I am delighted to welcome Agro-Biotech to Pivot…  With this acquisition, we are well positioned to enter the Québec cannabis market and attract experienced scientists to our organization.  Pivot will seek to expand its footprint in the province beginning immediately following financing activities which are underway.  After several months of identifying and discussing with potential partners in the cannabis space, the Pivot management team and our scientific advisors agreed that it was in the best interest of our shareholders to acquire the compliment of licenses which will enable us to develop our pipeline of patented formulation and delivery technologies all under one vertically integrated process from seed to derivatives.  Pivot will only work with partners who truly control their processes and have the finest infrastructure and qualified personnel.  We believe that these characteristics will define best in class products for wellness and health conscious consumers using bio-cannabis….”

This latest announcement follows a pattern of strong corporate development by Pivot Pharmaceuticals and uniquely positons the company to become a major force in the burgeoning cannabis markets not only in Canada but around the world.

For more information, visit the company’s website at www.PivotPharma.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com